Inhibition of complement by gold sodium thiomalate. 1981

D R Schultz, and J E Volanakis, and P I Arnold, and N L Gottlieb

UI MeSH Term Description Entries
D003169 Complement Inactivator Proteins Serum proteins that negatively regulate the cascade process of COMPLEMENT ACTIVATION. Uncontrolled complement activation and resulting cell lysis is potentially dangerous for the host. The complement system is tightly regulated by inactivators that accelerate the decay of intermediates and certain cell surface receptors. Complement Cytolysis Inhibiting Proteins,Complement Cytolysis Inhibitor Proteins,Complement Inactivating Proteins,Serum Complement Inactivators,Complement Inactivators, Serum,Inactivating Proteins, Complement,Inactivator Proteins, Complement,Inactivators, Serum Complement,Proteins, Complement Inactivating,Proteins, Complement Inactivator
D006052 Gold Sodium Thiomalate A variable mixture of the mono- and disodium salts of gold thiomalic acid used mainly for its anti-inflammatory action in the treatment of rheumatoid arthritis. It is most effective in active progressive rheumatoid arthritis and of little or no value in the presence of extensive deformities or in the treatment of other forms of arthritis. Aurothiomalate,Gold Thiomalate,Sodium Gold Thiomalate,Aurolate,Gold Disodium Thiomalate, Monohydrate,Gold Thiomalic Acid,Mercaptobutanedioic Acid Monogold(1+) Sodium Salt,Miocrin,Miocrisin,Monogold (1+) Disodium Thiomalate,Myochrysine,Myocrisin,Myocrysine,Sodium Aurothiomalate,Sodium Thiomalatoaurate,Tauredon,Aurothiomalate, Sodium,Gold Thiomalate, Sodium,Sodium Thiomalate, Gold,Thiomalate, Gold,Thiomalatoaurate, Sodium
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

D R Schultz, and J E Volanakis, and P I Arnold, and N L Gottlieb
January 1981, The Journal of rheumatology,
D R Schultz, and J E Volanakis, and P I Arnold, and N L Gottlieb
May 1978, Journal of immunology (Baltimore, Md. : 1950),
D R Schultz, and J E Volanakis, and P I Arnold, and N L Gottlieb
June 1983, British journal of pharmacology,
D R Schultz, and J E Volanakis, and P I Arnold, and N L Gottlieb
February 1970, Biochemical pharmacology,
D R Schultz, and J E Volanakis, and P I Arnold, and N L Gottlieb
March 1975, The Medical journal of Australia,
D R Schultz, and J E Volanakis, and P I Arnold, and N L Gottlieb
December 1978, Archives of dermatology,
D R Schultz, and J E Volanakis, and P I Arnold, and N L Gottlieb
June 1994, The Journal of rheumatology,
D R Schultz, and J E Volanakis, and P I Arnold, and N L Gottlieb
July 1982, Research communications in chemical pathology and pharmacology,
D R Schultz, and J E Volanakis, and P I Arnold, and N L Gottlieb
April 1990, The Journal of rheumatology,
D R Schultz, and J E Volanakis, and P I Arnold, and N L Gottlieb
May 1999, Clinical immunology (Orlando, Fla.),
Copied contents to your clipboard!